Big Sioux Wealth Management’s MiNK Therapeutics INKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-812
Closed -$9.49K – 233
2026
Q2
$9.49K Buy
+812
New +$9.46K 0.01% 257

Other funds holding INKT

Big Sioux Wealth Management's INKT Position: Q3 2026 in Review

Big Sioux Wealth Management sold out of MiNK Therapeutics (INKT) in Q3 2026, closing a stake of 812 shares — an estimated $9.49K sold.

Big Sioux Wealth Management first reported a position in INKT in Q2 2026 and held it in 1 quarter. The position peaked at $9.49K in Q2 2026. 26 funds tracked by Wall St. Rank hold INKT as of Q3 2026.

  • Big Sioux Wealth Management reported no remaining MiNK Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Big Sioux Wealth Management sold 812 MiNK Therapeutics shares in Q3 2026, an estimated $9.49K.
  • Big Sioux Wealth Management first reported a position in MiNK Therapeutics in Q2 2026 and held it in 1 quarter.
  • Big Sioux Wealth Management's MiNK Therapeutics position peaked at $9.49K in Q2 2026.
  • 26 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q3 2026.

Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.